Figure 4From: Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials Kaplan-Meier curves for DFS and OS according to HER2 gene status (log-rank test p-values). Back to article page